These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7735089)

  • 21. What happens when a demonstration project ends. Consequences for a clinic and its clients.
    Grella CE; Anglin MD; Rawson R; Crowley R; Hasson A
    J Subst Abuse Treat; 1996; 13(3):249-56. PubMed ID: 9017568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
    Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
    J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors associated with client-reported HIV infection among clients entering methadone treatment.
    MacGowan RJ; Fichtner RR; Swanson N; Collier C; Kroliczak A; Cole G
    AIDS Educ Prev; 1997 Jun; 9(3):205-17. PubMed ID: 9241388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methadone in maintenance treatment of narcotic addicts; joint revision of conditions for use; interim maintenance treatment; human immunodeficiency virus disease counseling--FDA and SAMHSA. Final rule.
    Fed Regist; 1993 Jan; 58(3):495-9. PubMed ID: 10171334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Methadone substitution treatment. Results of an evaluation of 3 years implementation in an Austrian province].
    Rittmannsberger H; Ruschak M; Silberbauer C
    Nervenarzt; 1994 May; 65(5):338-44. PubMed ID: 8052337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrating the methadone patient in the traditional addiction inpatient rehabilitation program--problems and solutions.
    Kipnis SS; Herron A; Perez J; Joseph H
    Mt Sinai J Med; 2001 Jan; 68(1):28-32. PubMed ID: 11135503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.
    Van Den Berg C; Smit C; Van Brussel G; Coutinho R; Prins M;
    Addiction; 2007 Sep; 102(9):1454-62. PubMed ID: 17697278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methadone maintenance treatment (MMT): a review of historical and clinical issues.
    Joseph H; Stancliff S; Langrod J
    Mt Sinai J Med; 2000; 67(5-6):347-64. PubMed ID: 11064485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Administrative, social and clinical facilities of the implementation of the methadone program in Bordeaux].
    Tignol J
    Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():43-5. PubMed ID: 7880016
    [No Abstract]   [Full Text] [Related]  

  • 31. Methadone medical maintenance in primary care. An implementation evaluation.
    Merrill JO; Jackson TR; Schulman BA; Saxon AJ; Awan A; Kapitan S; Carney M; Brumback LC; Donovan D
    J Gen Intern Med; 2005 Apr; 20(4):344-9. PubMed ID: 15857492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Barriers and facilitators to primary care or human immunodeficiency virus clinics providing methadone or buprenorphine for the management of opioid dependence.
    Turner BJ; Laine C; Lin YT; Lynch K
    Arch Intern Med; 2005 Aug 8-22; 165(15):1769-76. PubMed ID: 16087826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Skills-training groups to reduce HIV transmission and drug use among methadone patients.
    Schilling RF; el-Bassel N; Hadden B; Gilbert L
    Soc Work; 1995 Jan; 40(1):91-101. PubMed ID: 7863377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Threshold models in a methadone programme evaluation.
    Saei A; Ward J; McGilchrist CA
    Stat Med; 1996 Oct; 15(20):2253-60. PubMed ID: 8910967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methadone maintenance: its future in skilled nursing facilities.
    Goldberg RJ; Grabowski R
    J Am Med Dir Assoc; 2003; 4(2):98-100. PubMed ID: 12807582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of drug addicts with methadone in medical practice-- problems of the treatment of heroin addicts with methadone in view of the HIV epidemic].
    Fuchs WJ
    Schweiz Rundsch Med Prax; 1988 Mar; 77(13):354-7. PubMed ID: 3375659
    [No Abstract]   [Full Text] [Related]  

  • 37. Reducing the risk of AIDS through methadone maintenance treatment.
    Ball JC; Lange WR; Myers CP; Friedman SR
    J Health Soc Behav; 1988 Sep; 29(3):214-26. PubMed ID: 3241064
    [No Abstract]   [Full Text] [Related]  

  • 38. Accessing additional community resources through case management to meet the needs of methadone clients.
    Dennis ML; Karuntzos GT; Rachal JV
    NIDA Res Monogr; 1992; 127():54-78. PubMed ID: 1436006
    [No Abstract]   [Full Text] [Related]  

  • 39. Reasons for discharge from methadone maintenance for addicts at high risk of HIV infection or transmission.
    Grella CE; Anglin MD; Wugalter SE; Rawson R; Hasson A
    J Psychoactive Drugs; 1994; 26(2):223-32. PubMed ID: 7931867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in the frequency of use and abuse of drugs by Los Angeles County methadone maintenance patients: an observation based on urine drug testings in 1975 and 1979.
    Budd RD
    Bull Narc; 1981; 33(1):27-30. PubMed ID: 6913413
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.